Quality-of-Care Indicators for HIV/AIDS
- PDF / 230,063 Bytes
- 16 Pages / 504.57 x 720 pts Page_size
- 83 Downloads / 261 Views
Dis Manage Health Outcomes 2000 Jun; 7 (6): 315-330 1173-8790/00/0006-0315/$20.00/0 © Adis International Limited. All rights reserved.
Quality-of-Care Indicators for HIV/AIDS Albert W. Wu,1 Allen Gifford,2,3 Steven Asch,4,3,5 Susan E. Cohn,6 Samuel A. Bozzette2,3 and Robin Yurk7 1 Departments of Health Policy and Management, and Epidemiology, School of Hygiene and Public Health and the Department of Medicine, School of Medicine, The Johns Hopkins University, Baltimore, Maryland, USA 2 The University of California San Diego, San Diego, California, USA 3 The RAND Corporation, Santa Monica, California, USA 4 VA Greater Los Angeles Healthcare System, Los Angeles, California, USA 5 The University of California Los Angeles, Los Angeles, California, USA 6 University of Rochester Medical Center, Rochester, New York, USA 7 The Foundation for Accountability, Portland, Oregon, USA
Contents Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1. Disease Burden . . . . . . . . . . . . . . . . . . . . . . . . . . . 2. Activities to Develop Quality-of-Care Measures for HIV/AIDS 3. Feasibility and Sampling . . . . . . . . . . . . . . . . . . . . . . 4. Measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.1 Health Outcomes . . . . . . . . . . . . . . . . . . . . . . . 4.2 Survival . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.3 Immunological and Virological Measures . . . . . . . . . 4.4 Disease Progression . . . . . . . . . . . . . . . . . . . . . . 4.5 Patient-Reported Outcomes . . . . . . . . . . . . . . . . 5. Prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6. Screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7. Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.1 Antiretroviral Treatment . . . . . . . . . . . . . . . . . . . 8. Monitoring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.1 Screening for Opportunistic Infections . . . . . . . . . . . 8.2 Prophylaxis Against Opportunistic Infections . . . . . . . 8.3 Treatment of Opportunistic Infections . . . . . . . . . . . 9. Symptom-Based Measures . . . . . . . . . . . . . . . . . . . . 10. Vaccination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11. Case-Mix Adjustment . . . . . . . . . . . . . . . . . . . . . . . 12. Issues in the Selection of Indicators . . . . . . . . . . . . . . . 13. Field Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abstract
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . .
Data Loading...
